The program would restore access to chain and independent pharmacies for TRICARE beneficiaries, who currently have to obtain non-generic medications through mail-order pharmacies or military treatment facilities.
See photos from the two-day fly in to Capitol Hill conducted by National Association of Chain Drug Store board members, during which they met with lawmakers to share the role pharmacy plays in the nation’s healthcare system.
The Food and Drug Administration has shared a list of drugs without patents or exclusivity that don't yet have generics, and has outlined a new plan for expediting review of generics of drugs with limited competition.
Rituxan Hycela contains hyaluronidase human, an enzyme that helps with the subcutaneous delivery of Rituxan's active ingredient, rituximab, allowing for faster administration compared with intravenous Rituxan.
The Preserving Patient Access to Compounded Medications Act of 2017 would clarify the Drug Quality and Security Act in a way that would align the statute with congressional intent to balance the issues of public safety and patient access.
The move makes Oregon the 14th state to pass a law banning dextromethorphan sales to patients younger than 18 years old, joining states across the country in recognizing that limiting teen access to DXM is a proven way to prevent abuse, the Consumer Healthcare Products Association said.
The National Community Pharmacists Association shared with the Centers for Medicare and Medicaid Service a list of provisions it hopes will be included in the final rule for managed care organizations.
The Supreme Court has overturned an appeals court decision which said Sandoz had to wait 180 days under federal law after receiving Food and Drug Administration approval to launch its biosimilar of Amgen’s Neupogen (filgrastim), Zarxio (filgrastim-sndz).
The National Association of Chain Drug Stores has submitted a statement to the House Ways and Means Committee highlighting pharmacy’s role in the healthcare system and urging passage of provider status legislation.
According to the QuintilesIMS Institute’s 2017 Medicine Use and Spending report, Truvada had $3.1 billion in sales on an invoice price basis in 2016, ranking 17th among the top 20 medicines in the U.S. based on invoice spending.
The National Association of Chain Drug Stores and the American Pharmacists Association shared their concerns with the Trump Administration about the potential impact of drug importation on patient safety and the delivery of value-based care.